Rosenblatt Lifts Micron Price Target to $300 on AI Memory Demand
Rosenblatt raised its price target on Micron Technology (NASDAQ: MU) to $300 from a previous $250, while reiterating a Buy rating on the stock. The firm cited accelerating demand for DRAM and NAND memory driven by artificial intelligence applications as the key factor for the revision.
The investment firm's analysis points to a constrained DRAM supply growth through 2026. This limited supply is coupled with increasing demand from AI accelerators, which require high-bandwidth memory (HBM), and the deployment of AI models on edge devices like PCs and smartphones. This aligns with the company's long-term mission and vision in the evolving tech landscape.
According to Rosenblatt, both DRAM and NAND prices are increasing more rapidly than previously anticipated, which prompted the firm to revise its earnings estimates for Micron upward. The analysts noted that constrained supply growth across the memory industry is expected to sustain elevated pricing, creating a favorable environment for Micron's stock and its overall financial health.
Investors can find more details on the company's background in its history and ownership summary and review its investor profile for further information.

Micron Technology, Inc. (MU) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.